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Abstract
On January 19, 2012, after 131 years of operation, the Eastman Kodak Company filed for Chapter 11
protection in U.S. bankruptcy court. No doubt some people were surprised by this filing, because they
grew up at a time when bright yellow boxes of film accompanied every family vacation and celebration.
Those who were paying more attention offered many explanations for the bankruptcy. Central among
them was that Kodak was late to recognize that it was not in the film and camera business: it was in the
imaging business. With the advent of digital imaging, Kodak was outpaced by other companies that could
better achieve consumer goals.
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What Business Are We In? The Emergence of Health
as the Business of Health Care
David A. Asch, M.D., M.B.A., and Kevin G. Volpp, M.D., Ph.D.

O

n January 19, 2012, after
131 years of operation, the
Eastman Kodak Company filed
for Chapter 11 protection in U.S.
bankruptcy court. No doubt some
people were surprised by this filing, because they grew up at a
time when bright yellow boxes of
film accompanied every family
vacation and celebration. Those
who were paying more attention
offered many explanations for the
bankruptcy. Central among them
was that Kodak was late to recognize that it was not in the film
and camera business: it was in
the imaging business. With the
advent of digital imaging, Kodak
was outpaced by other companies
that could better achieve consumer goals.
This lesson has been repeated
many times over. In 1960, the editor of the Harvard Business Review,
Theodore Levitt, wrote that the
failure of railroads could be explained in part by the myopic
view that they were in the railroad business and not the transportation business, which left
them vulnerable to competition
from cars, trucks, and planes.1
Levitt argued that it’s always better to define a business by what
consumers want than by what a
company can produce. Kodak had
built a successful enterprise producing cameras, film, and photographic paper and chemicals, but
what people wanted was images,
and so when a better way to get
those images was found, its customers followed.
The analogous situation in
health care is that whereas doctors and hospitals focus on pro888

ducing health care, what people
really want is health. Health care
is just a means to that end —
and an increasingly expensive one.
If we could get better health some
other way, just as we can now
produce images without film and
transport people and freight without railroads, then maybe we
wouldn’t have to rely so much on
health care.
To some of us, the point may
seem both obvious and irrelevant.
We might concede that even if
people don’t intrinsically desire
doctors’ visits, medications, surgery, and imaging, those services
are still the way to get people the
health they want. Although that
may be true, the leaders of Kodak
or the railroads may have had
similar thoughts in their own day.
Yet they seem to have missed
some signals. What signals might
we be missing?
One signal is that while much
of recent U.S. medical practice
proceeds as if health and disease
were entirely biologic, our understanding of health’s social determinants has become deeper and
more convincing. An enormous
body of literature supports the
view that differences in health
are determined as much by the
social circumstances that underlie them as by the biologic processes that mediate them. Examples include the Whitehall study
of British civil servants that revealed that civil-service grade is
more strongly associated with
mortality than any broad biomedical measure2; research conducted
in the Veterans Affairs health care
system and elsewhere demonstrat-
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ing the persistence of health disparities even within fixed health
insurance and delivery systems;
and models of fundamental causes
that provide a conceptual explanation of how such disparities
can persist over time, following
different pathways in changing
circumstances.3
None of this evidence suggests
that health care is not an important determinant of health or that
it’s not among the most easily
modifiable determinants. After all,
we have established systems to
support the writing of prescriptions and the performance of surgery or imaging but have found
no easy way to cure poverty or
relieve racial residential segregation. But the evidence does suggest that health care as conventionally delivered explains only a
small amount — perhaps 10% —
of premature deaths as compared
with other factors, including social context, environmental influences, and personal behavior.4
If health care is only a small part
of what determines health, perhaps organizations in the business of delivering health need to
expand their offerings.
A second signal is that whereas in the past there was some
implicit presumption that doctors
and hospitals provide health care
of consistently high quality, that
presumption is now being challenged, and we’re getting much
better at identifying, measuring,
reporting, and targeting health
outcomes. For decades, health
plans, states, and the federal government have been publishing
quality data at the levels of con-
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ditions, populations, physicians,
and hospitals. Some of these
data reflect processes — for example, which hospitals are better
at giving aspirin to patients with
acute myocardial infarction —
but more and more data reflect
outcomes, not just for patients
within hospitals but for the populations surrounding them. The
Mobilizing Action toward Community Health project has been
publishing ratings of county-level
population health. Employers increasingly focus on employee wellness, on one side, and disease
management, on the other. Research funding increasingly supports efforts to improve these
measures and effectively communicate outcomes. Each of these
approaches has advanced incrementally over decades. This trend
reveals an interest in what ultimately happens to individuals and
populations.
A third signal is that health
care financing is testing these
pathways too. Payment systems
that will not reimburse preventable readmissions or that bundle
payments for goals or episodes
of care rather than visits reflect a

population approach to health focused on outcomes rather than
processes. Today’s standard approach of reimbursing for office
visits and hospitalizations is likely
to be displaced once better measures of outcomes can provide a
substitute that’s more relevant to
our key goals. If we can measure
success, why pay for process? If
we can get the images we want in
a better way, why use photographic film, paper, and chemicals?
In the future, successful doctors, hospitals, and health systems
will shift their activities from delivering health services within
their walls toward a broader range
of approaches that deliver health.
Although we’re seeing the earliest steps in this shift toward accountability for health, we currently lack both good tools for moving
forward in any substantial way
and more established pathways for
redirecting financing toward those
outcomes.5 What do we need to
move from a product-oriented industry to a customer-oriented one?
Surely, Kodak’s employees and
shareholders lost something as
their company lost business to other firms. But the world is at least

narrowly better thanks to the ways
photographs are now produced.
Doctors and hospitals who pay
attention to the business they are
actually in — defined by the outcomes their “customers” seek —
will leave the doctors and hospitals who don’t behind, captured
in a Kodak moment.
Disclosure forms provided by the authors are available with the full text of this
article at NEJM.org.
From the Center for Health Equity Research
and Promotion, Philadelphia Veterans Affairs Medical Center; the Penn Medicine
Center for Innovation; and the Wharton
School, University of Pennsylvania — all in
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This article was published on August 29,
2012, at NEJM.org.
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From Sick Care to Health Care — Reengineering Prevention
into the U.S. System
Farshad Fani Marvasti, M.D., M.P.H., and Randall S. Stafford, M.D., Ph.D.

A

lthough the United States
pays more for medical care
than any other country, problems
abound in our health care system. Unsustainable costs, poor
outcomes, frequent medical errors, poor patient satisfaction,
and worsening health disparities
all point to a need for transformative change.1 Simultaneously,
we face widening epidemics of

obesity and chronic disease. Cardiovascular disease, cancer, and
diabetes now cause 70% of U.S.
deaths and account for nearly
75% of health care expenditures.2
Unfortunately, many modifiable
risk factors for chronic diseases
are not being addressed adequately. A prevention model, focused
on forestalling the development
of disease before symptoms or
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life-threatening events occur, is
the best solution to the current
crisis.
Disease prevention encompasses all efforts to anticipate the
genesis of disease and forestall
its progression to clinical manifestations. A focus on prevention
does not imply that disease can
be eliminated but instead embraces Fries’s model of “morbid-

september 6, 2012

The New England Journal of Medicine
Downloaded from nejm.org on August 16, 2017. For personal use only. No other uses without permission.
Copyright © 2012 Massachusetts Medical Society. All rights reserved.

889

